WILMINGTON, Mass., July 11 /PRNewswire/ -- OmniSonics Medical Technologies, Inc., a developer of advanced medical devices, today announced the appointment of Len Farris to the position of Vice President, Marketing.
Mr. Farris comes to OmniSonics from Boston Scientific Corporation, where he most recently served as Global Director of Marketing, Endoscopy. With Boston Scientific since 1998, Mr. Farris recently led the development and commercialization of the 1st Access & Visualization Platform for Endoscopy. During his tenure at Boston Scientific, he also held various Sales and Marketing management positions. In 1995 he joined Pfizer, Inc., where he served in various sales roles. Previously, Mr. Farris served in the United States Air Force from 1987 to 1995, where he was an aircrew member on the KC- 135 aircraft, and held various leadership roles, including Wing Chief of Safety. While in the Air Force, he was awarded the Air Medal and Distinguished Service Medal as a result of his service in the Desert Storm War.
Mr. Farris holds an MBA from Embry Riddle Aeronautical University and a BS in Business Administration from East Carolina University. In addition, he has attended Business Executive Education at Harvard and Columbia Business Schools.
"It is a pleasure to welcome Len to our senior management team. With Len's extensive experience in market assessment, global product development, and business development and commercialization, we are looking forward to his making a major contribution in the marketing and commercialization of our products for vascular occlusive disease," said Richard Ganz, President and CEO.
"Joining OmniSonics at this time is most exciting as we prepare to enter the medical device arena with our OmniWave Technology platform. I look forward to working with the OmniSonics team to help commercialize and introduce products that improve the lives of patients," said Mr. Farris.
About OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc., based in Wilmington, MA, is a venture-backed medical device company focused on developing breakthrough products for the treatment of vascular occlusive disease.
About the OmniWave Technology Platform
The Company plans to introduce products based on the Company's patented OmniWave(TM) Technology, the first technology to enable the delivery of low- power acoustic energy around the active length of a small diameter wire in a diseased blood vessel. The OmniWave(TM) System is designed to rapidly reduce occlusive materials to red blood cell size particles without harming healthy tissue.
Clearance for use in peripheral vascular disease is expected in 2007. Additional clinical trials are planned for other indications.
Contact: Rhonda Rosenbaum OmniSonics Medical Technologies, Inc. 978-657-9980, X348 rrosenbaum@omnisonics.com
OmniSonics Medical Technologies, Inc.CONTACT: Rhonda Rosenbaum of OmniSonics Medical Technologies, Inc.,+1-978-657-9980, X348
Web site: http://www.omnisonics.com/
